Sonnet Biotherapeutics Holdings Inc.

12/16/2025 | Press release | Distributed by Public on 12/17/2025 05:03

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 16, 2025
Accession Number: 0001493152-25-026943
Submission Type: POS AM
CIK: 0001106838
Company Name: Sonnet BioTherapeutics Holdings, Inc.
File Number: 333-280705
Sonnet Biotherapeutics Holdings Inc. published this content on December 16, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 17, 2025 at 11:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]